Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Sex differences in schizophrenia.

Abel KM, Drake R, Goldstein JM.

Int Rev Psychiatry. 2010;22(5):417-28. doi: 10.3109/09540261.2010.515205. Review.

PMID:
21047156
2.

Sex differences in schizophrenia, a review of the literature.

Leung A, Chue P.

Acta Psychiatr Scand Suppl. 2000;401:3-38. Review.

PMID:
10887978
3.

Gender and schizophrenia.

Tamminga CA.

J Clin Psychiatry. 1997;58 Suppl 15:33-7. Review.

PMID:
9427875
4.

The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia.

Salem JE, Kring AM.

Clin Psychol Rev. 1998 Nov;18(7):795-819. Review.

PMID:
9827322
6.

Gender differences in substance use disorders.

Brady KT, Randall CL.

Psychiatr Clin North Am. 1999 Jun;22(2):241-52. Review.

PMID:
10385931
7.

Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.

Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JM, Bilder R.

J Clin Psychiatry. 1996;57 Suppl 9:5-9. Review.

PMID:
8823344
8.

Gender and schizophrenia.

Canuso CM, Pandina G.

Psychopharmacol Bull. 2007;40(4):178-90. Review.

PMID:
18227787
9.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

10.

[Schizophrenia and addiction: An evaluation of the self-medication hypothesis].

Potvin S, Stip E, Roy JY.

Encephale. 2003 May-Jun;29(3 Pt 1):193-203. Review. French.

PMID:
12876543
11.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
12.

Older people with chronic schizophrenia.

Karim S, Overshott R, Burns A.

Aging Ment Health. 2005 Jul;9(4):315-24. Review.

PMID:
16019287
13.

[Gender differences in schizophrenia. A literature review].

Usall J, Busquets E, Araya S, Ochoa S, Gost A.

Actas Esp Psiquiatr. 2000 May-Jun;28(3):178-85. Review. Spanish.

PMID:
11000700
14.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
15.

Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia.

Rao ML, K├Âlsch H.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:83-96. Review.

PMID:
12650683
16.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
17.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Woods SW, Gueorguieva RV, Baker CB, Makuch RW.

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. Review.

PMID:
16143728
18.

Suicide in schizophrenia.

Perenyi A, Forlano R.

Neuropsychopharmacol Hung. 2005 Sep;7(3):107-17. Review.

PMID:
16493874
19.

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV.

J Clin Psychiatry. 2002 Oct;63(10):892-909. Review.

PMID:
12416599
20.

The evaluation of women with schizophrenia.

Canuso CM, Goldstein JM, Green AI.

Psychopharmacol Bull. 1998;34(3):271-7. Review.

PMID:
9803753

Supplemental Content

Support Center